Document Detail


Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
MedLine Citation:
PMID:  19819922     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Revised guidelines for the staging and response criteria of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) were recently published to include the expanding role of positron emission tomography/computed tomography (PET/CT) using (18)F-fluoro-2-deoxyglucose. Here, we discuss the new guidelines and the need for standardized PET acquisition and interpretation in HL and NHL. We also discuss how the role for CT is evolving in the process of making treatment decisions and provide insight on how best to standardize the use of PET/CT for making therapeutic choices.
Authors:
Dominique Delbeke; Sigrid Stroobants; Eric de Kerviler; Christian Gisselbrecht; Michel Meignan; Peter S Conti
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The oncologist     Volume:  14 Suppl 2     ISSN:  1549-490X     ISO Abbreviation:  Oncologist     Publication Date:  2009  
Date Detail:
Created Date:  2009-10-12     Completed Date:  2010-01-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9607837     Medline TA:  Oncologist     Country:  United States    
Other Details:
Languages:  eng     Pagination:  30-40     Citation Subset:  IM    
Affiliation:
Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Fluorodeoxyglucose F18 / diagnostic use
Hodgkin Disease / drug therapy,  radiography*,  radionuclide imaging*
Humans
Lymphoma, Non-Hodgkin / drug therapy,  radiography*,  radionuclide imaging*
Neoplasm Staging
Positron-Emission Tomography / methods
Practice Guidelines as Topic
Prognosis
Radiopharmaceuticals / diagnostic use
Tomography, X-Ray Computed / methods*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymp...
Next Document:  Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete...